The Scientific Research Team at Revel Pharmaceuticals is responsible for conducting cutting-edge research and development of therapeutic enzymes designed to address age-associated molecular damage. This team collaborates to identify, engineer, and validate enzymes that target diseases of aging such as osteoarthritis, kidney disease, cardiovascular disease, skin aging, and diabetes-related complications. Their work forms the foundation for the company's innovative treatments and therapeutic solutions.